Navigation Links
Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur

on, which
is a counter-reaction of the body potentially decreasing the efficacy of current drug therapy1. In contrast to small molecule inhibitors, which display large variations in serum drug levels throughout the day, the vaccine-induced anti-angiotensin II antibodies were found to decline with a half-life of about 4 months. This may lead to a practically continuous inhibition of angiotensin II for weeks, which may in part account for the minor reactive rise observed in plasma renin concentration, and to the potent effect of the vaccine in early morning hours, as is further explained in the quote of Dr. Müller below.

A further important finding of the study is the dependence of efficacy on both the dose of the vaccine and the levels of induced anti-angiotensin II antibodies. Two doses of the vaccine, 100 ?g and 300 ?g, were tested in the trial. The induced anti-angiotensin antibody levels were significantly higher at the 300 ?g than at the 100 ?g dose (p=0.0098). Accordingly, blood pressure reduction was much larger and only significant at the 300 ?g dose (p=0.0498). Efficacy was thus driven by a longlasting, although reversible antibody response. Dr. Philipp Müller, EVP Clinical Development at Cytos Biotechnology comments on the study results:

“These data highlight a very important new aspect of the vaccine CYT006-AngQb, namely its exceptionally good control of the early morning blood pressure. So far, inhibition of the reninangiotensin system has been studied clinically only with small molecule inhibitors, which all produce a daily pattern of peaks and troughs in drug levels. Here, a trough in drug levels coincides with a natural rise of the blood pressure in early morning hours. The combination of these effects may lead to insufficient control of the early morning blood pressure surge. An intervention with a different pharmacokinetic profile like the vaccine approach, which avoids daily peaks and troughs in drug l
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
2. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
3. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
4. Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
5. Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hypertension
6. Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist
7. New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard Therapy in Treatment of Hypertension
8. Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
9. King Pharmaceuticals Announces Plan to Present Results from Phase III Clinical Trial Evaluating ALTACE as Monotherapy and in Combination with Hydrochlorothiazide at the American Society of Hypertension Annual Meeting
10. Landmark Findings From ECLIPSE Program Show Improved Control of Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
11. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
Post Your Comments:
(Date:9/2/2015)... , Sept. 2, 2015  MEI Pharma, Inc. ... the clinical development of novel therapies for cancer, today ... 2015. Logo - http://photos.prnewswire.com/prnh/20140805/133834 ... year, I am quite pleased with how the Company ... P. Gold , Ph.D., President and Chief Executive Officer ...
(Date:9/2/2015)... 2, 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD; ... treatment of chronic pain, announced today that the company,s ... FBR Second Annual Healthcare Conference and BioCentury NewsMakers Conference.  ... FBR Second Annual Healthcare Conference Date:  Wednesday, September ... No presentation, investor meetings only ...
(Date:9/2/2015)... British Columbia and MENLO ... --  DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" ... the development and commercialization of new cancer therapies, ... entitled, "A Comparison of the Mechanisms and ... Ovarian Tumor Models Harboring Wild-type and Mutant p53," ...
Breaking Medicine Technology:MEI Pharma Reports Fiscal Year 2015 Results 2MEI Pharma Reports Fiscal Year 2015 Results 3MEI Pharma Reports Fiscal Year 2015 Results 4MEI Pharma Reports Fiscal Year 2015 Results 5MEI Pharma Reports Fiscal Year 2015 Results 6MEI Pharma Reports Fiscal Year 2015 Results 7Relmada Therapeutics to Participate in Two Upcoming Investor Conferences 2DelMar Pharmaceuticals Announces Expansion of VAL-083 Development Program to Include Ovarian Cancer 2DelMar Pharmaceuticals Announces Expansion of VAL-083 Development Program to Include Ovarian Cancer 3DelMar Pharmaceuticals Announces Expansion of VAL-083 Development Program to Include Ovarian Cancer 4
... Jan. 3, 2012 Reportlinker.com announces ... is available in its catalogue: ... Capital (PE/VC) Activity in Medical Devices ... Companies has Increased over the Past ...
... CHICAGO, Dec. 30, 2011 Four free stock picks are ... research firm highlights one Zacks #1 Rank Strong Buy or ... four main styles of investing: Aggressive Growth, Growth & Income, ... The four highlighted picks are: Chemtura Corporation ...
Cached Medicine Technology:Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years 2Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years 3Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years 4Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years 5Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years 6Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years 7Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years 8Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years 9Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years 10Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years 11Zacks Releases Four Powerful ''Buy'' Stocks: Chemtura, Cardinal Health, HiTech Pharmacal and Gardner Denver 2Zacks Releases Four Powerful ''Buy'' Stocks: Chemtura, Cardinal Health, HiTech Pharmacal and Gardner Denver 3Zacks Releases Four Powerful ''Buy'' Stocks: Chemtura, Cardinal Health, HiTech Pharmacal and Gardner Denver 4
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... reputation for the telling the truth about medicine and health, truths that other ... video blog, where he plans to regularly debunk certain misconceptions surrounding cholesterol, metabolically ...
(Date:9/1/2015)... , ... September 01, 2015 , ... For many men, the first thing they notice ... were often forced to wear a looser fitting shirt with a collar that doesn’t close ... a finger between their collar and skin all day because it’s uncomfortable. Now men ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... Economics, the author explained how many dental practices across the country are switching ... Manufacturing) technology. According to Beverly Hills cosmetic dentist Dr. Sam Saleh of Ora ...
(Date:9/1/2015)... ... 2015 , ... The Journal of Pain Research has published the ... , As corresponding author Mr Christopher Malone says “Migraine headache is a painful chronic ... to better understand how migraine headaches impact the lives of migraineurs. We asked migraineurs ...
(Date:9/1/2015)... CA (PRWEB) , ... September 01, 2015 , ... According ... Medical Association, individuals with type 2 diabetes that participated in a three year study ... three years down the line if they elected weight loss surgery at the onset ...
Breaking Medicine News(10 mins):Health News:Dr. Michael Rothman, NJ’s Leading Holistic Doctor, Presents a Video Blog that Discusses the Most Confusing and Interesting Current Medical Topics 2Health News:Getting Rid of Double Chins: New FDA Approved Kybella Treatment Proving Very Popular Among Professional Men at Crutchfield Dermatology 2Health News:Article on CAD/CAM Dental Technology Highlights the Advantages of 21st Century Dentistry, Notes Ora Dentistry Spa 2Health News:Migraine, treatment, comorbidities, and quality of life published by Dove Medical Press 2Health News:Recent Journal Article on Diabetes Remission Adds to the Growing Pile Of Evidence in Favor of Bariatric Surgery, Says Dr. Feiz and Associates 2
... 19 Delta Dental of Illinois has ... of Illinois at Chicago,College of Dentistry to ... renovations are complete, the clinic will be ... Dentistry Clinic., (Photo: http://www.newscom.com/cgi-bin/prnh/20071219/AQW128 ), ...
... Ind., Dec. 19 Zimmer Holdings, Inc.,(NYSE: ZMH ... announced,today it will be participating in the 26th Annual ... at 12:00 p.m. Eastern Time., A live webcast ... website at http://investor.zimmer.com . The webcast will,be archived ...
... takes the first step in offering nationwide services, ... announced its plan to expand its services to four ... Area during,the summer of 2007, and is now expanding ... The company hosts a website where healthcare,providers and patients ...
... (MGH) researchers have identified a new molecular pathway that ... This early-stage kidney disease affects 100 million people around ... the kidneys filtering structures. Blocking this pathway could ... slow the process of kidney failure. The research ...
... Device might aid in the detection and monitoring of cancer, ... U.S. team has developed a microchip device that can detect ... has a silicon chip with about 80,000 microscopic posts. Each ... expressed by most solid tumors. The device is able to ...
... Massachusetts General Hospital (MGH) Biomicroelectromechanical Systems (BioMEMS) Resource Center ... device that can isolate, enumerate and analyze circulating tumor ... viable cells from solid tumors carried in the bloodstream ... Because of their rarity and fragility, it has ...
Cached Medicine News:Health News:Delta Dental of Illinois Announces Major Gift to University of Illinois at Chicago College of Dentistry 2Health News:Receptor protein appears to be key in breakdown of kidney filtration 2Health News:Receptor protein appears to be key in breakdown of kidney filtration 3Health News:Microchip Spots Stray Tumor Cells in the Bloodstream 2Health News:Microchip-based device can detect rare tumor cells in bloodstream 2Health News:Microchip-based device can detect rare tumor cells in bloodstream 3
... test setup, try Cadwell paired disc electrodes. ... The custom-molded contacts are 10 mm (0.4 ... solid stainless steel with a locator pin ... color coded and available in twisted pairs. ...
... Video Camera System (NTSC)With Maxenon PowerPlus ... surgeon's eye view of any procedure. ... or digital files for later use. ... 8" to 36". Automatic Iris and ...
... chloride ring electrodes fit pediatric ... with minicrocodile clip lead wires ... (4 in) long, 0.6 cm ... package contains 50 individually sealed ...
Four disposable disc electrodes are pre-gelled and attached to wires in red, blue, black and green. 4mil carbon film, Ag/AgCl coated. Each package contains 20 individually sealed sets of four leads....
Medicine Products: